HK1232255A1 - 評估 風險的方法 - Google Patents
評估 風險的方法Info
- Publication number
- HK1232255A1 HK1232255A1 HK17105553.9A HK17105553A HK1232255A1 HK 1232255 A1 HK1232255 A1 HK 1232255A1 HK 17105553 A HK17105553 A HK 17105553A HK 1232255 A1 HK1232255 A1 HK 1232255A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pml
- assessing risk
- assessing
- risk
- pml pml
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461945778P | 2014-02-27 | 2014-02-27 | |
PCT/US2015/018069 WO2015131078A1 (en) | 2014-02-27 | 2015-02-27 | Method of assessing risk of pml |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1232255A1 true HK1232255A1 (zh) | 2018-01-05 |
Family
ID=54009661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK17105553.9A HK1232255A1 (zh) | 2014-02-27 | 2017-06-05 | 評估 風險的方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10955422B2 (zh) |
EP (2) | EP3110976B1 (zh) |
ES (1) | ES2818823T3 (zh) |
HK (1) | HK1232255A1 (zh) |
WO (1) | WO2015131078A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11180807B2 (en) | 2011-11-04 | 2021-11-23 | Population Bio, Inc. | Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease |
DK2812452T3 (da) | 2012-02-09 | 2020-06-29 | Population Bio Inc | Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser |
EP2895621B1 (en) | 2012-09-14 | 2020-10-21 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
DK3511422T3 (da) | 2013-11-12 | 2023-02-06 | Population Bio Inc | Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose |
CA3045931A1 (en) * | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
JP7213637B2 (ja) * | 2018-08-07 | 2023-01-27 | 日鉄テックスエンジ株式会社 | 整備管理装置、整備管理方法及びプログラム |
HRP20221504T1 (hr) * | 2018-08-08 | 2023-03-31 | Pml Screening, Llc | Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja |
CN112798771B (zh) * | 2021-03-31 | 2021-07-30 | 宝枫生物科技(北京)有限公司 | 用于诊断脑白质病变的生物标志物及其应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
NZ215865A (en) | 1985-04-22 | 1988-10-28 | Commw Serum Lab Commission | Method of determining the active site of a receptor-binding analogue |
CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US4868103A (en) | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
EP0552108B1 (en) | 1992-01-17 | 1999-11-10 | Lakowicz, Joseph R. | Energy transfer phase-modulation fluoro-immunoassay |
US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
DK0929578T3 (da) | 1996-02-09 | 2003-08-25 | Abbott Lab Bermuda Ltd | Humane antistoffer, der binder human TNFalfa |
WO2001055112A1 (en) | 2000-01-27 | 2001-08-02 | American Cyanamid Company | Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
AU2011203815B2 (en) | 2010-01-11 | 2015-11-26 | Biogen Ma Inc. | Assay for JC virus antibodies |
HUE061244T2 (hu) | 2011-05-31 | 2023-06-28 | Biogen Ma Inc | A PML kockázat értékelésének módszere |
CA2850885A1 (en) * | 2011-10-17 | 2013-04-25 | Westfaelische Wilhelms-Universitaet Muenster | Assessment of pml risk and methods based thereon |
-
2015
- 2015-02-27 WO PCT/US2015/018069 patent/WO2015131078A1/en active Application Filing
- 2015-02-27 ES ES15754919T patent/ES2818823T3/es active Active
- 2015-02-27 EP EP15754919.7A patent/EP3110976B1/en active Active
- 2015-02-27 US US15/120,573 patent/US10955422B2/en active Active
- 2015-02-27 EP EP20172750.0A patent/EP3757224A3/en not_active Withdrawn
-
2017
- 2017-06-05 HK HK17105553.9A patent/HK1232255A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3110976A4 (en) | 2017-11-22 |
US10955422B2 (en) | 2021-03-23 |
ES2818823T3 (es) | 2021-04-14 |
EP3757224A3 (en) | 2021-03-17 |
US20170016919A1 (en) | 2017-01-19 |
WO2015131078A1 (en) | 2015-09-03 |
EP3110976A1 (en) | 2017-01-04 |
EP3757224A2 (en) | 2020-12-30 |
EP3110976B1 (en) | 2020-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201406151D0 (en) | Method | |
GB201409558D0 (en) | Method | |
GB201406155D0 (en) | Method | |
GB201408119D0 (en) | Method | |
HK1232255A1 (zh) | 評估 風險的方法 | |
GB201413240D0 (en) | Method | |
HK1216546A1 (zh) | 評估 風險的方法 | |
GB201403470D0 (en) | Method | |
GB201410022D0 (en) | Method | |
GB201421135D0 (en) | Assessment method | |
GB201410101D0 (en) | Method | |
GB201411500D0 (en) | Method | |
ZA201508427B (en) | Method of connecting metal strips | |
GB201414419D0 (en) | Method of testing | |
GB201412802D0 (en) | Method | |
GB201409128D0 (en) | Method | |
GB201412736D0 (en) | Method | |
GB201412226D0 (en) | Method | |
GB201409234D0 (en) | Method | |
GB201409101D0 (en) | Method | |
SG11201605798WA (en) | Demolishing method | |
GB201413612D0 (en) | Method | |
GB201601843D0 (en) | Method of assessing risk | |
GB201701719D0 (en) | Method of assessing risk | |
GB201420712D0 (en) | Assessment method |